On-demand therapy for Los Angeles grade A and B reflux esophagitis: Esomeprazole versus omeprazole

Journal of the Formosan Medical Association

Volumn 102, Issue 9, 2003, Pages 607-612

  Kao, Ai Wen ^a   Sheu, Bor Shyang ^a   Sheu, Ming Jen ^a,b   Chang, Ye Mei ^a   Huang, Shu Feng ^a   Chuang, Chiao Hsiung ^a   Lai, Yung Ling ^a,b   Kao, Yeh Heuy ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Anti ulcer argents; Drug administration schedule; Gastroesophagel reflux; Oesophagitis; Omeprazole; Peptic

Indexed keywords

ESOMEPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; SCORING SYSTEM; STOMACH ACID; SYMPTOMATOLOGY; TAIWAN;

ANTI-ULCER AGENTS; DRUG ADMINISTRATION SCHEDULE; ESOPHAGITIS, PEPTIC; FEMALE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; TREATMENT OUTCOME;

EID: 0346496078     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Malfertheiner P, Megraud F, O'Morain C, et al: Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus report. Aliment Pharmacol Ther 2002;16:167-80.
2. Howden CW, Hunt RH: Treating Helicobacter pylori. Arch Intern Med 1998;158:2396-8.
3. Spechler SJ: Epidemiology and natural history of gastroesophageal reflux disease. Digestion 1992;51(Suppl 1):24-9.
4. Hunt RH: Importance of pH control in the management of GERD. Arch Intern Med 1999;159:649-57.
5. Chiba N, De Gara CJ, Wilkinson JM, et al: Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997;112:1798-810.
6. Holloway RH, Dent J, Narielvala F, et al: Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux esophagitis. Gut 1996; 38:649-54.
7. Richardson P, Hawkey CJ, Stack WA: Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs 1998;56:307-35.
8. Tytgat GN: Long-term therapy for refluxive esophagitis. N Engl J Med 1995;333:1148-50.
9. Dent J, Brun J, Fendrick A, et al: An evidence-based appraisal of reflux disease management-the Genval workshop report. Gut 1999;44:S1-16.
10. Talley NJ, Lauritsen K, Tunturi-Hihnala H, et al: Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of "on-demand" therapy for 6 months. Aliment Pharmacol Ther 2001;15:347-54.
11. Lind T, Havelund T, Lundell L, et al: On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis - a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999;13:907-14.
12. Junghard O, Hassan-Alin M, Hasselgren G: The effect of AUC and Cmax of esomeprazole on acid secretion and intragastric pH. Gastroenterology 2000;118:A64.
13. Thitiphuree S, Talley NJ: Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy. Int J Clin Pract 2000;54:537-41.
14. Vakil NB, Shaker R, Johnsn DA, et al: The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blinded, placebo-controlled study of efficacy and safety. Aliment Pharmacol Ther 2001;15:927-35.
15. Kahrilas PJ, Falk GW, Johnson DA, et al: Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators. Aliment Pharmacol Ther 2000;14:1249-58.
16. Lind T, Rydberg L, Kyleback A, et al: Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000;14:861-7.
17. Lundell LR, Dent J, Bennet JR, et al: Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45: 172-80.
18. Carlsson R, Dent J, Bolling-Sternevald E, et al: The usefulness of a structured questionnare in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33:1023-9.
19. Richter JE, Kahrilas PJ, Johnason J, et al: Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 2001;96:656-65.